Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin A treatment in children with Legg-Calvé-Perthes disease
2007-002812-24Phase 4Terminated
- Sponsor
- University Hospital Vienna
- Start
- Sep 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-arm trial of botulinum toxin type A in Legg-Calvé-Perthes disease (LCPD), sponsored by University Hospital Vienna. Primary endpoints: Change in range of motion, Change in pain level and 1 more. Started Sep 2007; status: terminated.
02
Drugs
botulinum toxin type A
03
Conditions
Legg-Calvé-Perthes disease (LCPD)
Beyond the preview
Go deeper on 2007-002812-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002812-24.